Related Experiment Video
Updated: Jun 17, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity
Nir Arbel1, Varda Shoshan-Barmatz
1Department of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Abstract:
The antiapoptotic proteins of the Bcl-2 family are expressed at high levels in many types of cancer. However, the mechanism by which Bcl-2 family proteins regulate apoptosis is not fully understood. Here, we demonstrate the interaction of Bcl-2 with the outer mitochondrial membrane protein, voltage-dependent anion channel 1 (VDAC1). A direct interaction of Bcl-2 with bilayer-reconstituted purified VDAC was demonstrated, with Bcl-2 decreasing channel conductance. Expression of Bcl-2-GFP prevented apoptosis in cells expressing native but not certain VDAC1 mutants. VDAC1 sequences and amino acid residues important for interaction with Bcl-2 were defined through site-directed mutagenesis. Synthetic peptides corresponding to the VDAC1 N-terminal region and selected sequences bound specifically, in a concentration- and time-dependent manner, to immobilized Bcl-2, as revealed by the real-time surface plasmon resonance. Moreover, expression of the VDAC1-based peptides in cells over-expressing Bcl-2 prevented Bcl-2-mediated protection against staurosporine-induced apoptotic cell death. Similarly, a cell-permeable VDAC1-based synthetic peptide was also found to prevent Bcl-2-GFP-mediated protection against apoptosis. These results point to Bcl-2 as promoting tumor cell survival through binding to VDAC1, thereby inhibiting cytochrome c release and apoptotic cell death. Moreover, these findings suggest that interfering with the binding of Bcl-2 to mitochondria by VDAC1-based peptides may serve to potentiate the efficacy of conventional chemotherapeutic agents.
Insights
The anti-apoptotic protein Bcl-2 promotes cancer cell survival by binding to the mitochondrial protein VDAC1, inhibiting cell death. VDAC1-based peptides disrupt this interaction, potentially enhancing cancer therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Bcl-2 family proteins are crucial regulators of apoptosis and are often overexpressed in cancers.
- The precise mechanisms by which Bcl-2 proteins exert their antiapoptotic functions, particularly at the mitochondrial level, remain incompletely elucidated.
Purpose of the Study:
- To investigate the interaction between the antiapoptotic protein Bcl-2 and the outer mitochondrial membrane protein VDAC1.
- To elucidate the functional consequences of this interaction on apoptosis and to explore its therapeutic potential.
Main Methods:
- Bicelle reconstitution assays to study direct Bcl-2 and VDAC1 interaction.
- Site-directed mutagenesis of VDAC1 to identify interaction sites.
- Surface plasmon resonance (SPR) to analyze peptide-Bcl-2 binding kinetics.
- Cell-based assays using Bcl-2-GFP and VDAC1 mutants to assess apoptosis.
- Treatment with VDAC1-based synthetic peptides to evaluate inhibition of Bcl-2-mediated survival.
Main Results:
- Bcl-2 directly binds to VDAC1, reducing its channel conductance.
- Specific VDAC1 sequences and residues were identified as critical for Bcl-2 interaction.
- VDAC1-based peptides specifically bind to Bcl-2 and inhibit Bcl-2-mediated protection against apoptosis.
- Cell-permeable VDAC1 peptides prevent Bcl-2-mediated cell survival.
Conclusions:
- Bcl-2 promotes tumor cell survival by binding to VDAC1 on the outer mitochondrial membrane, thereby blocking cytochrome c release and apoptosis.
- Targeting the Bcl-2-VDAC1 interaction with VDAC1-based peptides represents a potential strategy to sensitize cancer cells to chemotherapy.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Caspases
Apoptosis
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...

